Comparative Study of Ropivacaine and Ropivacaine With Dexmeditomedine in TAP Blocks

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Pregnancy
Interventions
DRUG

Ropivacaine + Dexmedetomidine

Patients satisfying inclusion criteria will receive Subarachnoid Block with Bupivacaine Heavy 0.5% (11 mg/2.2 ml) with 25 micrograms of fentanyl. At the end of the procedure, bilateral TAP block will be performed using Landmark Technique with 2.5 mg/kg of ropivacaine and 1 micrograms/kg dexmedetomidine (combination drug) diluted with 0.9% saline to a total volume of 40 ml (20 ml each side) for the TAP block

OTHER

Ropivacaine

Patients satisfying inclusion criteria will receive Subarachnoid Block with Bupivacaine Heavy 0.5% (11 mg/2.2 ml) with 25 micrograms of fentanyl. At the end of the procedure, bilateral TAP block will be performed using Landmark Technique with 2.5 mg/kg of ropivacaine diluted with 0.9% saline to a total volume of 40 ml (20 ml each side)

Trial Locations (1)

831001

Tata Main Hospital, Jamshedpur

All Listed Sponsors
lead

Tata Main Hospital

OTHER

NCT02472522 - Comparative Study of Ropivacaine and Ropivacaine With Dexmeditomedine in TAP Blocks | Biotech Hunter | Biotech Hunter